400-859-2883
Your location:Home >News center >Huateng News

Huateng News

02-182022

Supply COVID-19 Drug Paxlovid Intermediat…

We can offer pharmaceutical intermediate contract manufacturing services.

Supply COVID-19 Drug Paxlovid Intermediates
01-212022

Global CDMO for Intermediates & APIs

Huateng Pharma is a global provider in contract development and manufacturing for intermediates and APIs.

Global CDMO for Intermediates & APIs
12-202021

Holiday Greetings from Huateng Pharma

Wishing you and your family the merriest Christmas and loveliest New Year ahead!

Holiday Greetings from Huateng Pharma
11-182021

Visit Huateng Pharma at CPhI China 2022

Visit us at CPhI China, 20-22 December, 2022, SNIEC, Shanghai, China. Huateng Pharma will exhibit in booth W1D08.

Visit Huateng Pharma at CPhI China 2022
04-302021

Huateng Pharma Completed Series B Round o…

Recently, Hunan Huateng Pharmaceutical Co., Ltd. completed a series B financing of 117 million yuan led by CITIC Securities.

Huateng Pharma Completed Series B Round of Financing
12-192020

Huateng Pharma CPHI Shanghai 2020 Exhibit…

On December 16, the 20th CPHI Shanghai 2020 (Chemical Pharmaceutical Ingredient) was grandly held at Shanghai New International Expo Centre (SNIEC), PR China.

Huateng Pharma CPHI Shanghai 2020 Exhibition Ended Successfully